Molecular mechanisms of opioid receptor signal transduction

British Journal of Anaesthesia

Volumn 81, Issue 1, 1998, Pages 12-19

  Jordan, Bryen ^a   Devi, Lakshmi A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesics opioid; Opioids, desensitization; Receptors opioid, down regulation; Receptors opioid, G protein coupled; Receptors opioid, internalization; Second messenger systems; Signal transduction

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; LIGAND; OPIATE RECEPTOR;

BINDING SITE; CONFORMATIONAL TRANSITION; DESENSITIZATION; INTERNALIZATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031874288     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/81.1.12     Document Type: Review

References (117)

1. Arden J, Segredo V, Wang Z, Lameh J, Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. Journal of Neurochemistry 1995; 65: 1636-1645.
2. Avidor-Reiss T, Zippel R, Levy R, Saya D, Ezra V, Barg J, Matus-Leibovitch N, Vogel Z. Kappa-opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. FEBS Letters 1995; 361: 70-74.
3. Befort K, Tabbara L, Kling D, Maigret B, Kieffer B. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition. Journal of Biological Chemistry 1996; 271: 10161-10168.
4. Blake A, Bot G, Li S, Freeman J, Reisine T. Differential agonist regulation of the human kappa-opioid receptor. Journal of Neurochemistry 1997; 68: 1846-1852.
5. Blume A. Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides. Proceedings of the National Academy of Sciences (USA) 1978; 75: 1713-1717.
6. Blume A. Opiate binding to membrane preparations of neuroblastoma x glioma hybrid cells NG108-15: effects of ions and nucleotides. Life Sciences 1978; 22: 1843-1852.
7. + and GTP. Proceedings of the National Academy of Sciences (USA) 1979; 76: 5626-5630.
8. Bourinet E, Soong T, Stea A, Snutch T. Determinants of the G-protein dependent opioid modulation of neuronal calcium channels. Proceedings of the National Academy of Sciences (USA) 1996; 93: 1486-1491.
9. Bradbury A, Smyth D, Snell C, Birdsall N, Hulme E. C-fragment of lipoprotein has a high affinity for brain opiate receptors. Nature (London) 1976; 260: 793-795.
10. Brown S, Stimmel B, Taub R, Kochwa S, Rosenfield R. Immunologic dysfunction in heroin addicts. Archives of Internal Medicine. 1974; 134: 1001-1014.
11. Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proceedings of the National Academy of Sciences (USA) 1993; 90: 5391-5393.
12. Buzas B, Rosenberger J, Cox B. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport 1996; 7: 1505-1508.
13. Chakrabarti S, Prather P, Yu L, Law P, Loh H. Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido GTP labeling of multiple G protein alpha subunits. Journal of Neurochemisty 1995; 64: 2534-2543.
14. Chakrabarti S, Yang W, Law P, Loh H. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Molecular Pharmacology 1997; 52: 105-113.
15. Chen G, Chalazonitis A, Shen K, Crain S. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell cultures. Brain Research 1988; 462: 372-377.
16. Chen Y, Mestek A, Liu J, Hurley J, Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Molecular Pharmacology 1993; 44: 8-12.
17. Childers S, Snyder S. Differential regulation by guanine nucleotides or opiate agonist and antagonist receptor interactions. Journal of Neurochemistry 1980; 34: 583-593.
18. Chiu T, Yung L, Wong Y. Inverse agonistic effect of ICI-174,864 on the cloned delta-opioid receptor: role of G protein and adenylyl cyclase activation. Molecular Pharmacology 1996; 50: 1651-1657.
19. Clapham D, Neer E. New roles for G-protein beta gamma-dimers in transmembrane signaling. Nature 1993; 365: 403-406.
20. Claude P, Wotta D, Zhang X, Prather P, McGinn T, Erickson L, Loh H, Law P. Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proceedings of the National Academy of Sciences (USA) 1996; 93: 5715-5719.
21. Cox B, Goldstein A, Li C. Opioid activity of a peptide, beta-endorphin (61-91), derived from beta-lipotropin. Proceedings of the National Academy of Sciences (USA) 1976; 73: 1821-1823.
22. Cruciani R, Dvorkin B, Morris S, Crain S, Makman M. Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proceedings of the National Academy of Sciences (USA) 1993; 90: 3019-3023.
23. Cvejic S, Devi LA. Dimerization of the δ opioid receptor: Implication for a role in receptor internalization. Journal of Biological Chemistry 1997; 272: 26959-26964.
24. Cvejic S, Trapaidze N, Cyr C, Devi LA. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. Journal of Biological Chemistry 1996; 271: 4073-4076.
25. Darlison M, Greten F, Harvey R, Kreienkamp H, Stühmer T, Zwiers H, Lederis K, Richter D. Opioid receptors from a lower vertebrate (Catostomus commersoni): Sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution. Proceedings of the National Academy of Sciences (USA) 1997; 94: 8214-8219.
26. Davis L, Ehrlich Y. Opioid peptides and protein phosphorylation. Advances in Experimental Medicine and Biology 1979; 116: 233-244.
27. Evans C, Keith Jr. D, Morrison H, Magendzo K, Edwards R. Cloning of a delta opioid receptor by functional expression. Science 1992; 258: 1952-1955.
28. + channels in sensory ganglion cells. Brain Research 1991; 558: 166-170.
29. Fantozzi R, Mullikin-Kilpatrick D, Blume A. Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlornaltrexamine. Molecular Pharmacology 1981; 20: 8-15.
30. Franklin P, Hoss W. Opiates stimulate low Km GTPase in brain. Journal of Neurochemistry. 1984; 43: 1132-1135.
31. Garzon J, Garcia-Espana A, Sanchez-Blazquez P. Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and G(x/z) transducer proteins in mouse periaqueductal gray matter. The Journal of Pharmacology and Experimental Therapeutics 1997; 281: 549-557.
32. Garzon J, Martinez-Pena Y, Sanchez-Blazquez P. Gx/z is regulated by mu but not delta opioid receptors in the stimulation of the low Km GTPase activity in mouse periaqueductal grey matter. European Journal of Neuroscience 1997; 9: 1194-1200.
33. Genazzani A, Petraglia F. Opioid control of leutinizing hormone secretion in humans. Journal of Steroid Biochemistry 1989; 33: 751-755.
34. Goldstein A, Fischli W, Lowney L, Hunkapiller M, Hood L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proceedings of the National Academy of Sciences (USA) 1981; 78: 7219-7223.
35. Goldstein A, Naidu A. Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Molecular Pharmacology 1989; 36: 265-272.
36. Harada H, Ueda H, Katada T, Ui M, Satoh M. Phosphorylated mu-opioid receptor purified from rat brains lacks functional coupling with Gi1, a GTP-binding protein in reconstituted lipid vesicles. Neuroscience Letters 1990; 113: 47-49.
37. Hazum E, Chang K, Leighton H, Lever O jr, Cuatrecasas P. Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking. Biochemical and Biophysical Research Communications 1982; 104: 347-353.
38. Henry D, Grandy D, Lester H, Davidson N, Chavkin C. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. Molecular Pharmacology 1995; 47: 551-557.
39. Houslay M, Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. Trends in Biochemical Sciences 1997; 22: 217-224.
40. Hsia J, Moss J, Hewlett E, Vaughan M. ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. Journal of Neurochemistry 1984; 259: 1086-1090.
41. Huang L. Cellular mechanisms of excitatory and inhibitory actions of opioids. In: Tseng, L. The Pharmacology of Opioid Peptides. Singapore: Harwood Academic Publishers, 1995; 131-149.
42. Hughes J, Smith T, Kosterlitz H, Forthergill L, Morgan B, Morris H. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (London) 1975; 258: 577-579.
43. + exchange in neuroblastoma X glioma cells via a mechanism other than decreased cAMP accumulation. Journal of Neurochemistry 1987; 262: 17504-17509.
44. Johnson P, Wang J, Wang W, Unl G. Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover. Neuroreport 1994; 5: 507-509.
45. Jordan B, Cvejic S, Trapaidze N, Cherepanoff S, Unterwald E, Devi LA. Agonist mediated internalization of the μ,δ and κ opioid receptor types. Society of Neuroscience Abstracts. 1997; 2: 691.6.
46. Joseph D, Bidlack J. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. The Journal of Pharmacology and Experimental Therapeutics 1995; 272: 970-976.
47. Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S. Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor. Nature (London) 1982; 298: 245-249.
48. Keith D, Murray S, Zaki P, Chu P, Lissin D, Kang L, Evans C, von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. Journal of Biological Chemistry 1996; 271: 19021-19024.
49. Kieffer B, Befort K, Gaveriaux-Ruff C, Hirth C. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proceedings of the National Academy of Sciences (USA) 1992; 89: 12048-12052.
50. Kim D, Chin H, Klee W. Agonist regulation of the expression of the delta opioid receptor in NG108-15 cells. FEBS Letters 1995; 376: 11-14.
51. Kleuss C, Scherubl H, Hescheler J, Schultz G, Wittig B. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins. Science 1993; 259: 832-834.
52. Kong H, Raynor K, Yano H, Takeda J, Bell G, Reisine T. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. Proceedings of the National Academy of Sciences (USA) 1994; 91: 8042-8046.
53. Kong H, Raynor K, Yasuda K, Moe S, Portoghese P, Bell G, Reisine T. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. Journal of Biological Chemistry 1993; 268: 23055-23058.
54. Koski G, Klee W. Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proceedings of the National Academy of Sciences (USA) 1981; 78: 4185-4189.
55. Law P, Hom D, Loh H. Multiple affinity states of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Opiate agonist association rate is a function of receptor occupancy. Journal of Biological Chemistry 1985; 1985: 3561-3569.
56. Law P, Mcginn T, Wick M, Erickson L, Evans C, Loh H. Analysis of delta opioid receptor activities stably expressed in CHO cells lines: Function of receptor density? The Journal of Pharmacology and Experimental Therapeutics 1994; 211: 1686-1694.
57. Law S, Reisine T. Changes in the association of G protein subunits with the cloned mouse Delta opioid receptor on agonist stimulation. The Journal of Pharmacology and Experimental Therapeutics 1997; 281: 1476-1486.
58. Loh H, Smith A. Molecular characterization of opioid receptors. Annual Review of Pharmacology 1990; 30: 123-170.
59. MacDonald RL, Nelson PG. Specific-opiate-induced depression of transmitter release from dorsal root ganglion cells in culture. Science (Washington DC) 1978; 199: 1449-1451.
60. Maggi R, Pimpinelli F, Martini L, Piva F. Inhibition of leutinizing hormone-releasing hormone secretion by delta-opioid agonists in GT1-1 neuronal cells. Endocrinology 1995; 136: 5177-5181.
61. Meng F, Hoversten M, Thompson R, Taylor L, Watson S, Akil H. A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors: Potential role of extracellular domains. Journal of Neurochemistry 1995; 270: 12730-12736.
62. Minami M, Nakagawa T, Seki T, Onogi T, Aoki Y, Katao Y, Katsumata S, Satoh M. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor. Molecular Pharmacology 1996; 50: 1413-1422.
63. Minami M, Onogi T, Nakagawa T, Katao Y, Aoki Y, Katsumata S, Satoh M. DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu- and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors. FEBS Letters 1995; 364: 23-27.
64. Misawa H, Ueda H, Satoh M. Kappa-opioid agonist inhibits phospholipase C, possibly via an inhibition of G-protein activity. Neuroscience Letters 1990; 112: 324-327.
65. Mudge A, Leeman SE, Fischbach GD. Enkephalin inhibits the release of substance P from sensory neurons in culture and decreases action potential duration. Proceedings of the National Academy of Sciences (USA) 1979; 76: 526-530.
66. Muller S, Lohse M. The role of G-protein beta-gamma subunit in signal transduction. Biochemical Society Transactions. 1995; 23: 141-148.
67. Nagamatsu K, Suzuki K, Teshima R, Ikebuchi H, Terao T. Morphine enhances the phosphorylation of a 58 kDa protein in mouse brain membranes. Biochemical Journal 1989; 257: 165-171.
68. Nakanishi S, Inoue A, Kita T, Nakamura M, Chang A, Cohen S, Numa S. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature (London) 1979; 278: 423-427.
69. Neer E. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995; 80: 249-257.
70. Nestler E, Tallman J. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Molecular Pharmacology 1988; 33: 127-132.
71. Noda M, Furutani Y, Takahashi H, Toyosato M, Hirose T, Inayama S, Nakanishi S, Numa S. Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin. Nature (London) 1982; 295: 202-206.
72. North A. Opioid receptor types and membrane ion channels. Trends in Neurosciences. 1991; 9: 114-117.
73. Pasternak G, Simantov R, Snyder S. Characterization of an endogenous morphine-like factor (enkephalin) in mammalian brain. Molecular Pharmacology 1976; 12: 504-513.
74. Patrini G, Massi P, Ricevuti G, Mazzone A, Fossati G, Mazzucchelli I, Gori E, Parolaro D. Changes in opioid receptor density on murine splenocytes induced by in vivo treatment with morphine and methadone. The Journal of Pharmacology and Experimental Therapeutics 1996; 279: 172-176.
75. Pei G, Kieffer B, Lefkowitz R, Freedman N. Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Molecular Pharmacology 1995; 48: 173-177.
76. Periyasamy S, Hoss W. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain. Life Sciences 1990; 47: 219-225.
77. Pert C, Snyder S. Opiate receptor: Demonstration in nervous tissue. Science 1973; 179: 1011-1014.
78. Piros E, Hales T, Evans C. Functional analysis of cloned opioid receptors in transfected cell lines. Neurochemical Research 1996; 21: 1277-1285.
79. 3 cells. Molecular Pharmacology 1995; 47: 1041-1049.
80. a subunit and is similar to that of other opioid receptors. Molecular Brain Research 1995; 29: 336-346.
81. Prather P, McGinn T, Erickson L, Evans C, Loh H, Law P. Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density. Journal of Neurochemistry 1994; 269: 21293-21302.
82. Reisine T, Law S, Blake A, Tallent M. Molecular mechanisms of opiate receptor coupling to G proteins and effector systems. Annals of the New York Academy of Sciences 1996; 780: 168-175.
83. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Gea A, ed. The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1996; 521-555.
84. Rhim H, Miller R. Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. Journal of Neuroscience. 1994; 14: 7608-7615.
85. Ronnekleiv O, Bosch M, Cunningham M, Wagner E, Grandy D, Kelly M. Downregulation of mu-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment. Neuroscience Letters 1996; 216: 129-132.
86. Roy S, Loh H. Effects of opioids on the immune system. Neurochemical Research 1996; 21: 1375-1386.
87. Rusia K, Moises H. μ-Opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons. Journal of Neuroscience. 1995; 15: 4315-4327.
88. Rusin K, Giovannuci D, Stuenkel E, Moises H. Kappa-opioid receptor activation modulates calcium currents and secretion in isolated neuroendocrine nerve terminals. Journal of Neuroscience. 1997; 17: 6565-6574.
89. Schafer M, Martin R. Opioid peptides in the pituitary: a hormone, a panacrine modulator and a peptide in search of function. Biological Chemistry. 1994; 375: 737-740.
90. Segredo V, Burford N, Lameh J, Sadee W. A constitutively internalizing and recycling mutant of the mu-opioid receptor. Journal of Neurochemistry 1997; 68: 2395-2404.
91. Shapira M, Baumhaker Y, Sarne Y. Long-term regulation of opioid receptors in neuroblastoma and lymphoma cell lines. Journal of Neuroimmunology 1997; 76: 145-152.
92. Sharma S, Klee W, Niremberg M. Morphine receptors as regulators of adenylate cyclase activity. Proceedings of the National Academy of Sciences (USA) 1975; 72: 590-594.
93. Simon E. Opioid receptors and endogenous opioid peptides. Medicinal Research Reviews. 1991; 11: 357-374.
94. 3H etorphine to rat brain homogenate. Proceedings of the National Academy of Sciences (USA) 1973; 70: 1947-1949.
95. Smart D, Lambert D. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends in Pharmocological Sciences 1996; 17: 264-269.
96. Standifer K, Rossi G, Pasternak G. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Molecular Pharmacology 1996; 50: 293-298.
97. Sternini C, Spann M, Anton B, Keith D jr, Bunnett N, von Zastrow M, Evans C, Brecha N. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proceedings of the National Academy of Sciences (USA) 1996; 93: 9241-9246.
98. Tai K, Bian C and Wong T. Kappa-opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sciences 1992; 51: 909-913.
99. Tallent M, Dichter M, Reisine T. Coupling to the cloned kappa and mu opioid receptors to the inwardly rectifier potassium current is differentially regulated. Society of Neuroscience Abstracts 1995; 21: 532.11.
100. Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Phamacologica et Toxicologica 1973; 32: 317-319.
101. Trapaidze N, Keith D, Cvejic S, Evans C, Devi LA. Sequestration of the delta opioid receptor: Role of the C terminus in agonist-mediated internalization. Journal of Biological Chemistry 1996; 271: 29279-29285.
102. Traynor J. Subtypes of κ-opioid receptor: Fact or fiction? Trends in Pharmacological Sciences. 1989; 10: 52-53.
103. Traynor J, Elliot J. δ-opioid receptor subtypes and cross talk with μ-receptors. Trends in Pharmacological Sciences. 1993; 14: 84-85.
104. Uhl G, Ryan J, Schwartz J. Morphine alters preproenkephalin gene expression. Brain Research 1988; 459: 391-397.
105. Vachon L, Costa T, Herz A. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. Molecular Pharmacology 1987; 31: 159-168.
106. Valiquette M, Vu H, Vue S, Wahlestedt C, Walker P. Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands. Journal of Biological Chemistry 1996; 271: 18789-18796.
107. Varga E, Li X, Stropova D, Zalewska T, Landsman R, Knapp R, Malatynska E, Kawai K, Mizusura A, Nagase H, Calderon S, Rice K, Hruby V, Roeske W, Yamamura H. The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists. Molecular Pharmacology 1996; 50: 1619-1624.
108. Wang W, Shahrestanifar M, Jin J, Howells R. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proceedings of the National Academy of Sciences (USA) 1995; 92: 12436-12440.
109. 2+ channels. Journal of Neuroscience 1995; 15: 4124-4132.
110. Wiley J, Moises H, Gross R, MacDonald R. Dynorphin A-mediated reduction in multiple calcium currents involves a G(o) alpha-subtype G protein in rat primary afferent neurons. Journal of Neurophysiology 1997; 77: 1338-1348.
111. Wilkinson M, Jacobson W, Wilkinson D. Brain slices in radioligand binding assays: quantification of opiate, benzodiazepines and beta-adrenergic (CGP-12177) receptors. Progress in Neuro-psychopharmacology and Biological Psychiatry 1984; 8: 621-626.
112. Wilson M, Burt A, Milligan G, Anderson N. Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70/s6k/p85s6k S6 kinase. Biochemical Journal 1997; 325: 217-222.
113. Wolleman M. Recent developments in the research of opioid receptor subtypes molecular characterization. Journal of Neurochemistry 1990; 54: 1095-1101.
114. Xie G, Meng F, Mansour A, Thompson R, Hoversten M, Goldstein A, Watson S, Akil H. Primary stucture and functional expression of a guinea pig kappa opioid (dynorphin) receptor. Proceedings of the National Academy of Sciences (USA) 1994; 91: 3779-3783.
115. Xue J, Chen C, Zhu J, Kunapuli S, Deriel J, Yu L, Liuchen L. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. Journal of Neurochemistry 1994; 269: 30195-30199.
116. Yaksh TL. The spinal actions of opioids. In: Herz, A, ed. Handbook of Experimental Pharmacology. Opioids II. Berlin: Springer-Verlag, 1993; 53-90.
117. Yasuda K, Raynor K, Kong H, Breder C, Takeda J, Reisine T, Bell G. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proceedings of the National Academy of Sciences (USA) 1993; 90: 6736-6740.